Efficacy of satralizumab as monotherapy

BestPractice | Sep 2019 | ECTRIMS 2019 |

Jeffrey L Bennett present in this MEDtalk the result of a randomised, double-blind, Phase 3 clinical trial comparing satralizumab monotherapy with placebo according to protocol-defined relapse.